by Kyle McGuire | Mar 10, 2017
VALEANT CANADA Vyloma Mandate The number one issue for all pharmaceutical treatments is enabling compliance. With some diseases unfortunately, there are no “cures”, only “management” therapy options. Genital warts is a disease that falls into this category. Our role...
by Kyle McGuire | Mar 10, 2017
CIPHER PHARMACEUTICALS Actikerall Mandate Ease of use and application is so simple with this product it’s practically cosmetic! Cipher Pharmaceuticals is a growing specialty company with a focus on dermatology. Actikerall™, an Actinic Keratosis (AK) topical...
by Kyle McGuire | Mar 9, 2017
LEO PHARMA Psoriassist Mandate Psoriasis is not contagious, but its unsightly appearance makes it an extremely unsocial disease. Leo Pharma embarked on a groundbreaking journey to create a national psoriasis program and the first-of-its-kind B2B education program for...
by Kyle McGuire | Mar 1, 2017
BAUSCH HEALTH Headlining Brand Drama Not an eye sore any more. Or should we say lip sore? This new topical prescription therapy was also the first combination treatment for cold sores in Canada. 3H launched it to physicians, delivering brand identity and main...
by Kyle McGuire | Feb 27, 2017
ADRIEN GAGNON Vitalizing Brand Relevancy Re-branding is a term we use when we are mandated to modernize a heritage brand, enabling it to once again resonate with its market. After 60 years, this Quebec natural health products provider was losing ground. Its market...
